• 1
    Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A & Holtmann G. AGA technical review: evaluation of dyspepsia. Gastroenterology 1998; 114: 58295.
  • 2
    Talley NJ, Zinsmeister AR, Schleck CD & Melton LJ. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 125968.
  • 3
    Talley NJ, Axon A, Bytzer P, Holtmann G, Lam SK & Zanten SV. Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998. Aliment Pharmacol Ther 1999; 13: 113548.DOI: 10.1046/j.1365-2036.1999.00584.x
  • 4
    Hansen JM, Bytzer P & Schaffalitzky de Muckadell OB. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 36874.
    Direct Link:
  • 5
    Finney JS, Kinnersley N, Hughes M, O’Bryan-Tear CG & Lothian J. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998; 26: 31220.
  • 6
    Talley NJ, Meineche-Schmidt V & Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12: 105565.DOI: 10.1046/j.1365-2036.1998.00410.x
  • 7
    Jones RH & Baxter G. Lansoprazole 30 mg daily versus ranitdine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther 1997; 11: 5416.
  • 8
    Stanghellini V, Tosetti C & Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 103642.
  • 9
    Jian R, Ducrot F & Ruskone A, et al. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci 1989; 34: 65764.
  • 10
    Stanghellini V, Tosetti C & Paternico A, et al. Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 1999; 94: 20805.
    Direct Link:
  • 11
    Malagelada JR & Distrutti E. Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures. Drugs 1996; 52: 494506.
  • 12
    Kellow JE, Cowan H & Shuter B, et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995; 9: 15360.
  • 13
    De Groot GH & De Both PS. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study. Aliment Pharmacol Ther 1997; 11: 1939.
  • 14
    Champion MC, MacCannell KL & Thomson AB, et al. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Can Cisapride NUD Study Group. Can J Gastroenterol 1997; 11: 12734.
  • 15
    Yeoh KG, Kang JY & Tay HH, et al. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial. J Gastroenterol Hepatol 1997; 12: 138.
  • 16
    Holtmann G & Talley NJ. Functional dyspepsia. Current treatment recommendations. Drugs 1993; 45: 91830.
  • 17
    Feighnner SD, Tan CP & McKee KK, et al. Receptor for motilin identified in the human gastrointestinal system. Science 1999; 284: 21848.DOI: 10.1126/science.284.5423.2184
  • 18
    Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993; 105: 188699.
  • 19
    Kendall BJ, Chakravarti A, Kendall E, Soykan I & McCallum RW. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy–antrectomy gastroparesis. Aliment Pharmacol Ther 1997; 11: 3815.
  • 20
    DiBaise JK & Quigley EM. Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center’s experience. J Clin Gastroenterol 1999; 28: 1314.
  • 21
    Verhagen MA, Samsom M, Maes B, Geypens BJ, Ghoos YF & Smout AJ. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. Aliment Pharmacol Ther 1997; 11: 107786.
  • 22
    Verlinden M, Craft C, Olson C, Morrison P & Kroodsma G. Abbott-812290, a new macrolide agent, dose-dependently accelerates solid gastric emptying (GE) in healthy volunteers. Gastroenterology 1997; 112: A846A846(Abstract).
  • 23
    Ghoos YF, Maes BD & Geypens BJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104: 16407.
  • 24
    Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA & Nair KS. 13C octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 1997; 112: 115562.
  • 25
    Lee JS, Camilleri M, Zinsmeister A, Burton D, Choi M-G & Nair KS. Accurate, simple measurement of gastric emptying by 13C octanoic acid breath test (OBT) in diabetics. Gastroenterology 1999; 116: G4207G4207.
  • 26
    Veldhuyzen Zanten SJ, Cleary C & Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91: 66073.
  • 27
    Nyren O, Adami HO & Bates S, et al. Self-rating of pain in nonulcer dyspepsia: a methodological study comparing a new fixed point scale and the visual analog scale. J Clin Gastroenterol 1987; 9: 40814.
  • 28
    Sturm A, Holtmann G, Goebell H & Gerken G. Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 1999; 60: 4227.
  • 29
    Clarke MJ, Wright T & Bertrand PP, et al. Erythromycin derivatives ABT229 and GM611 act on motilin receptors in the rabbit duodenum. Clin Exp Pharmacol Physiol 1999; 26: 2425.DOI: 10.1046/j.1440-1681.1999.03022.x
  • 30
    Galmiche JP, Belbende B, Perri F & Andriulli A. 13C octanoic acid breath test. Gut 1998; 43(Suppl. 3): S2830.
  • 31
    Tack J, Piessevaux H, Coulie B, Caenepeel P & Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 134652.
  • 32
    Bruley des Varannes S, Parys V, Ropert A, Chayvialle JA, Roze C & Galmiche JP. Erythromycin enhances fasting and postprandial proximal gastric tone in humans. Gastroenterology 1995; 109: 329.
  • 33
    Tack J, Broeckaert D, Coulie B & Janssens J. The influence of cisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther 1998; 12: 7616.DOI: 10.1046/j.1365-2036.1998.00366.x